redirect to https://www.japantimes.co.jp/news/2023/01/30/national/eisai%2Dpriority%2Dreview/<script>window.location.href = 'mailto:?subject=priority review status given to alzheimer&#39;s drug developed by eisai and biogen&body=https://www.japantimes.co.jp/news/2023/01/30/national/eisai%2Dpriority%2Dreview/';setTimeout(function(){window.location.href= 'https://www.japantimes.co.jp/news/2023/01/30/national/eisai%2Dpriority%2Dreview/'},500);</script>